Peer-Reviewed Articles

  • Phospho-Ser784-VCP Is Required for DNA Damage Response and Is Associated with Poor Prognosis of Chemotherapy-Treated Breast Cancer                                                               

      Zhu C*, Rogers A*, Asleh K*, Won J, Gao D, Leung S, Li S, Vij KR, Zhu J, Held JM, You Z, Nielsen TO, Shao J

      Cell Rep 2020 Jun 9; 31. doi: 10.1016/j.celrep.2020.107745. * Equal authorship

  • Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer                                                                Lei JT*, Shao J*, Zhang J*, Iglesia M*, Chan DW, Cao J, Anurag M, Singh P, He X, Kosaka Y, Matsunuma R, Crowder R, Hoog J, Phommaly C, Goncalves R, Ramalho S, Peres RMR, Punturi N, Schmidt C, Bartram A, Jou E, Devarakonda V, Holloway KR, Lai WV, Hampton O, Rogers A, Tobias E, Parikh PA, Davies SR, Li S, Ma CX, Suman VJ, Hunt KK, Watson MA, Hoadley KA, Thompson EA, Chen X, Kavuri SM, Creighton CJ, Maher CA, Perou CM, Haricharan S, Ellis MJ

      Cell Rep 2018 Aug 7;24(6):1434-1444.e7. doi: 10.1016/j.celrep.2018.07.009. * Equal authorship

Review Articles

Polyglutamine diseases: emerging concepts in pathogenesis and therapy
Shao J, Diamond MI
Hum Mol Genet 2007 Oct 15;16 Spec No 2:R115-23

"I have no special talent. I am only passionately curious." - Albert Einstein